Polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Time-restricted eating group: Participants are instructed to consume their diet ad libitum over 8 hours, and they are allowed to consume only calorie-free foods, non-starchy vegetables
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Body mass index of 25 kg/m2 and above Diagnosis of polycystic ovary syndrome by a gynecologist Age between 18 tp 40 years
Exclusion criteria
Exclusion criteria: Pregnancy and breastfeeding Menopause Daily calorie intake of less than 800 and more than 4200 kcal Use of dietary supplements, diuretics, or laxatives during the intervention period Participation in sports programs or changes in physical activity Use of weight-affecting medications A deviation from a specific eating pattern due to medical or other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Free androgen index (FAI). Timepoint: Measurement of Free androgen index (FAI) at the beginning of the study (before the start of the intervention) and 14 weeks after the start of the intervention. Method of measurement: It is calculated by dividing the numerical value of serum free testosterone by the value of sex hormone-binding globulin. | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: Weight measurement at the beginning of the study (before the start of the intervention) and 14 weeks after the start of the intervention. Method of measurement: Seca digital scale.;Body fat mass. Timepoint: Body fat mass measurement at the beginning of the study (before the start of the intervention) and 14 weeks after the start of the intervention. Method of measurement: Body analyzer.;Prolactin levels. Timepoint: Prolactin level measurement at the beginning of the study (before the start of the intervention) and 14 weeks after the start of the intervention. Method of measurement: Biochemical analysis.;Total testosterone level. Timepoint: Total testosterone level measurement at the beginning of the study (before the start of the intervention) and 14 weeks after the start of the intervention. Method of measurement: Biochemical analysis.;Luteinizing hormone level. Timepoint: luteinizing hormone level measurement at the beginning of the study (before the start of the intervention) and 14 weeks after the start of the intervention. Method of measurement: Biochemical analysis.;Follicle-stimulating hormone level. Timepoint: Follicle-stimulating hormone level measurement at the beginning of the study (before the start of the intervention) and 14 weeks after the start of the intervention. Method of measurement: Biochemical analysis.;Sex hormone-binding globulin level. Timepoint: Sex hormone-binding globulin level measurement at the beginning of the study (before the start of the intervention) and 14 weeks after the start of the intervention. Method of measurement: Biochemical analysis.;Serum indicators of glucose metabolism. Timepoint: Serum indicators of glucose metabolism measurement at the beginning of the study (before the start of the intervention) and 14 weeks after the start of the intervention. Method of measurement: Biochemical analysis.;Progesterone levels. Timepoint: Progesterone level measurement at the beginning of the study (before the start | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNeda Dolatkhah
Tabriz University of Medical Sciences
Outcome results
None listed